AdaptDx for AMD
Prevent Blindness Caused by AMD
We’re Among the First
Unger Eye Care is among the first to offer an innovative test, the AdaptDx, to help detect and monitor age-related macular degeneration (AMD) in its earliest stages. The AdaptDx is a simple, non-invasive test that measures the time it takes a patient’s vision to adjust from bright light to darkness, a process known as dark adaptation. Drs. Thomas and Alice Unger can diagnose AMD before any vision loss occurs, and put a plan place to help preserve vision.
AMD is the Leading Cause of Blindness
“Age-related macular degeneration is the leading cause of adult blindness, and more than twice as common as glaucoma. It is a chronic disease that causes a part of your retina called the macula to slowly deteriorate as you get older and makes it difficult to recognize faces, read, watch TV, and drive,” said Dr. Unger. “Many of our patients over age 50 are having trouble seeing or driving at night – and this can be the first symptom of AMD. With the AdaptDx, we are able to quickly and easily measure dark adaptation to detect AMD in its earliest stages, which is critical to delaying significant vision loss.”
Who is at Risk?
Patients over age 50, specifically those who have trouble seeing or driving at night. Family History of Age Related Macular Degeneration
High Blood Pressure
Prevention is Key
“We are very excited to be one of the first practices to offer this state-of-the-art technology to help identify AMD in its earliest stages and help our patients take action to preserve their vision,” said Dr. Unger. “While there is not a cure for AMD yet, there are several lifestyle changes and supplements that have a proven track record of delaying the progression of the disease.”
The AdaptDx is the first and only diagnostic aid for the subclinical detection and management of age-related macular degeneration (AMD), the leading cause of adult blindness. The AdaptDx enables eye care professionals to detect AMD several years before physical changes to the retina are visible and allows them to monitor disease progression. This facilitates proactive treatment at each stage of this chronic disease to eliminate preventable blindness. Backed by more than 20 years of proven clinical research, the AdaptDx is an easy-to-use functional test that accurately measures dark adaptation, a key biomarker of AMD. The AdaptDx is made in the USA by MacuLogix, Inc. Visit www.MacuLogix.com for additional information.
Simple Test to Protect Your Vision
The AdaptDx test is a simple test that is easy to take. Nothing touches the patient’s eye and the test does not require pupil dilation. During the test, the patient looks into the AdaptDx in a darkened room, and presses a button every time they see a flashing light. The amount of time it takes to complete the test provides the doctor with vital information regarding the patient’s retinal function.